CD274 and neoplasm: Considering the combined positivity score (CPS: ≥1% of expression in both tumor and mononuclear inflammatory cells), in KEYNOTE-012 trial PD-L1 positivity was related to better RR, PFS, and OS, than considering only the tumor proportion score (≥1% of expression only in tumor cells) [58].